Is CGC stock a Buy, Sell, or Hold?

Based on our analysis, CGC is currently a HOLD with moderate confidence. 📊 HOLD: CGC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of CGC stock?

Our analysis estimates the fair value range for CGC to be between $1.14 and $1.27. The current price is $1.09.

What is the analyst price target for CGC?

The average Wall Street analyst price target for CGC is $1.85. This implies a potential upside of 66.4% from current levels.

CGC Stock Analysis: Buy, Sell, or Hold?

CGC - Canopy Growth Corporation Common Shares

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

$1.09

-0.02 (-1.80%) ▼

HOLD

MODERATE Confidence

Protect Your CGC Gains

Last Updated: January 30, 2026

Earnings: Feb 06, 2026 5d

Smart Money Accumulation

CGC is down 8.4% this week, but smart money is accumulating calls. Top strike: $1.5 2026-04-17 with 13,336 OI. Call ratio: 74% View Scanner →

Strength: 6.6/10

Get Alerted When CGC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: CGC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

In-depth Analysis How we analyze

Valuation Analysis: CGC is currently trading at $1.09, which is considered oversold relative to its 30-day fair value range of $1.14 to $1.27. The stock's valuation (Forward PE: 12.3) is in line with its historical norms (13.3). Remarkably, the market is currently pricing in an annual earnings decline of 2.5% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, CGC is in a downtrend. The price is currently testing key support at $1.09. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: CGC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.85 (+66.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Fair Price Range $1.14 - $1.27

Company Quality Score 54/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.1%

Protect Your Profits

Holding CGC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 66.4% below Wall St target ($1.85)
CAUTION: 5-day price weakness (-8.4%) - monitor closely

Fair Price Analysis

30-Day Fair Range $1.14 - $1.27

Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $1.09

Resistance Level $1.23

Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 12.33

Wall Street Target $1.85 (+66.4%)

Revenue Growth (YoY) 5.9%

Profit Margin -138.5%

Valuation Discount vs History -2.5% cheaper

PE vs Historical 12.3 vs 13.3 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -2.5% (market-implied from PE analysis)

1-Year Target $1.08 (-3%)

2-Year Target $1.06 (-5%)

3-Year Target $1.03 (-7%)

3-Yr Target (if PE normalizes) (PE: 12→13) $1.11 (0%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 12.3 to 13.3

Stabilization Target: $1.20 (+7.8%)

PE Expansion Potential: +7.8%

Last updated: January 31, 2026 12:35 AM ET
Data refreshes hourly during market hours. Next update: 1:35 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is CGC showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

M Shan Atkins SELL 2216 shares 2025-09-29

Theresa Yanofsky SELL 10408 shares 2025-09-29

Willy Kruh SELL 10451 shares 2025-09-29

View Insider Activity Scanner

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NBIX Neurocrine Biosciences I…	STRONG BUY 25 analysts	$179	62 BUY
ZTS Zoetis Inc	STRONG BUY 19 analysts	$158	56 HOLD
LNTH Lantheus Holdings Inc	STRONG BUY 13 analysts	$84	57 HOLD
BCRX BioCryst Pharmaceuticals…	STRONG BUY 12 analysts	$21	55 HOLD
HCM HUTCHMED DRC	STRONG BUY 14 analysts	$21	57 HOLD

NBIX Neurocrine Biosci…

62 BUY

ZTS Zoetis Inc

56 HOLD

LNTH Lantheus Holdings…

57 HOLD

BCRX BioCryst Pharmace…

55 HOLD

HCM HUTCHMED DRC

57 HOLD

Advanced CGC Option Strategies

Professional options setups generated by AI based on today's CGC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CGC

CGC Technical Chart CGC Price Prediction CGC Earnings Date CGC Investment Advisor CGC Fair Price Analyzer CGC Options Advisor CGC Options Chain CGC Options Analysis CGC Competitors

Compare CGC with Other Stocks

Create New Comparison

Tradestie